Islet cell autoantibodies: A case of a premature obituary

Pediatric Diabetes

Volumn 6, Issue 4, 2005, Pages 181-183

  Schatz, Desmond A ^a   Atkinson, Mark A ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PROTEIN ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

BLOOD SAMPLING; DIAGNOSTIC ACCURACY; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; PRIORITY JOURNAL; QUALITY CONTROL; RADIOIMMUNOASSAY; RISK FACTOR;

AUTOANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; ISLETS OF LANGERHANS;

EID: 29544433642     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-543X.2005.00128.x     Document Type: Editorial

References (8)

1. Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 1997: 20: 965-970.
2. Greenbaum CJ, Sears KL, Kahn SE, Palmer JP. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study. Diabetes 1994: 48: 170-175.
3. Schmidli RS, Colman PG, Harrison LC. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first degree relatives at risk for IDDM? J Autoimmun 1994: 7: 873-879.
4. Pietropaolo M, Yu S, Libman IM, Pietropaolo SL et al. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pediatr Diabetes 2005: 6: 184-192.
5. Bonifacio E, Genovese S, Braghi S et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995: 38: 816-822.
6. Cantor AB, Krischer JP, Cuthbertson DD et al. Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM. J Clin Endocrinol Metab 1995: 80: 3739-3743.
7. Bingley PJ, Christie MR, Bonifacio E et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994: 43: 1304-1310.
8. Krischer JP, Cuthbertson DD, Yu L et al. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 2003: 88: 103-108.